RAY DOL

Product NDC: 50066-057
11-digit product format: 500660057
Labeler code: 50066
Product ID: 50066-057_6613842a-e72d-4cd3-bc77-116df9161a99
Type: HUMAN OTC DRUG
Nonproprietary name: Pain Relieving Cream
Dosage form: CREAM
Route: TOPICAL
Labeler: Genomma Lab USA Inc.
Application: part348
Marketing category: OTC MONOGRAPH NOT FINAL
Marketing start: 2013-12-15
Marketing end: 0000-00-00
Substance: MENTHOL; METHYL SALICYLATE
Active strength: 100 mg/g; mg/g
NDC exclude flag: No
Listing certified through: 2019-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	50066-057		I	Inactivated by FDA		2026-10-05
excluded package	package	50066-057	50066-057-73	I	Inactivated by FDA		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 42 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	50066-057-73	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	50066-057-73	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	50066-057-73	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	50066-057-73	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	50066-057-73	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	50066-057-73	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	50066-057-73	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	50066-057-73	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	50066-057-73	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	50066-057-73	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	50066-057-73	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	50066-057-73	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	50066-057-73	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	50066-057-73	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	50066-057-73	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	50066-057-73	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	50066-057-73	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	50066-057-73	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	50066-057-73	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	50066-057-73	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	50066-057-73	`9bebd1f3094a…`	`5416666fcb17…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
50066-057-73	2020-01-31	C162847	48780-1	9d75b9d1-2496-f424-e053-dadaa90a57ce	ed7ee9b0-c64f-4c46-a08f-dc47fe73c381

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
50066-057-73	RAY DOL	1 in 1 CARTON	CREAM	1		1
50066-057-73	RAY DOL	85 g in 1 TUBE	CREAM	85		1

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
MENTHOL	ACTIVE INGREDIENT	L7T10EIP3A	RAY DOL (PAIN RELIEVING CREAM) CREAM [GENOMMA LAB USA INC.]	1
METHYL SALICYLATE	ACTIVE INGREDIENT	LAV5U5022Y	RAY DOL (PAIN RELIEVING CREAM) CREAM [GENOMMA LAB USA INC.]	1
MENTHOL	ACTIVE MOIETY	L7T10EIP3A	RAY DOL (PAIN RELIEVING CREAM) CREAM [GENOMMA LAB USA INC.]	1
SALICYLIC ACID	ACTIVE MOIETY	O414PZ4LPZ	RAY DOL (PAIN RELIEVING CREAM) CREAM [GENOMMA LAB USA INC.]	1
CARBOMER 940	INACTIVE INGREDIENT	4Q93RCW27E	RAY DOL (PAIN RELIEVING CREAM) CREAM [GENOMMA LAB USA INC.]	1
CETYL ALCOHOL	INACTIVE INGREDIENT	936JST6JCN	RAY DOL (PAIN RELIEVING CREAM) CREAM [GENOMMA LAB USA INC.]	1
OLETH-3 PHOSPHATE	INACTIVE INGREDIENT	8Q0Z18J1VL	RAY DOL (PAIN RELIEVING CREAM) CREAM [GENOMMA LAB USA INC.]	1
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	RAY DOL (PAIN RELIEVING CREAM) CREAM [GENOMMA LAB USA INC.]	1
TROLAMINE	INACTIVE INGREDIENT	9O3K93S3TK	RAY DOL (PAIN RELIEVING CREAM) CREAM [GENOMMA LAB USA INC.]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	RAY DOL (PAIN RELIEVING CREAM) CREAM [GENOMMA LAB USA INC.]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50066-057	RAY DOL (PAIN RELIEVING CREAM) CREAM [GENOMMA LAB USA INC.]	1	Legacy NDC, 2 package rows	20140108_ed7ee9b0-c64f-4c46-a08f-dc47fe73c381.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
LAV5U5022Y	METHYL SALICYLATE	119-36-8	METHYL SALICYLATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
311498	menthol 10 % / methyl salicylate 15 % Topical Cream	PSN	ed7ee9b0-c64f-4c46-a08f-dc47fe73c381	1
1486400	Ray Dol (menthol 10 % / methyl salicylate 15 % ) Topical Cream	PSN	ed7ee9b0-c64f-4c46-a08f-dc47fe73c381	1
1486400	menthol 100 MG/ML / methyl salicylate 150 MG/ML Topical Cream [Ray Dol]	SBD	ed7ee9b0-c64f-4c46-a08f-dc47fe73c381	1
311498	menthol 100 MG/ML / methyl salicylate 150 MG/ML Topical Cream	SCD	ed7ee9b0-c64f-4c46-a08f-dc47fe73c381	1
311498	menthol 10 % / methyl salicylate 15 % Topical Cream	SY	ed7ee9b0-c64f-4c46-a08f-dc47fe73c381	1
311498	menthol 10 GM / methyl salicylate 15 GM per 100 GM Topical Cream	SY	ed7ee9b0-c64f-4c46-a08f-dc47fe73c381	1
1486400	Ray Dol (menthol 10 % / methyl salicylate 15 % ) Topical Cream	SY	ed7ee9b0-c64f-4c46-a08f-dc47fe73c381	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
50066-057-73	50066005773	1 in 1 CARTON	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
RAY DOL - Genomma Lab USA Inc. \| Faria LLC dba Sheffield Pharmaceuticals	Genomma Lab USA Inc. \| Faria LLC dba Sheffield Pharmaceuticals	2014-01-07	HUMAN OTC DRUG LABEL	1